Status:
COMPLETED
Observational Study to Evaluate the Safety of Levemir® in Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice condition...
Eligibility Criteria
Inclusion
- Type 1 or 2 diabetes
- Including newly diagnosed not on insulin or insulin analogue treatment
- Selection at the discretion of the physician
- Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older
Exclusion
- Current treatment with Levemir®
- Previously enrolled in the study
- Hypersensitivity to Levemir®
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
2282 Patients enrolled
Trial Details
Trial ID
NCT00706017
Start Date
September 1 2007
End Date
July 1 2008
Last Update
October 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Mexico City, Mexico